Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice.
Takeuchi T, Maeta K, Ding X, Oe Y, Takeda A, Inoue M, Nagano S, Fujihara T, Matsuda S, Ishigaki S, Sahashi K, Minakawa EN, Mochizuki H, Neya M, Sobue G, Nagai Y. Takeuchi T, et al. Among authors: matsuda s. Mol Ther Nucleic Acids. 2023 Jan 16;31:353-366. doi: 10.1016/j.omtn.2023.01.006. eCollection 2023 Mar 14. Mol Ther Nucleic Acids. 2023. PMID: 36817728 Free PMC article.
Identifying the Trends of Urinary microRNAs within Extracellular Vesicles for Esophageal Cancer.
Hisaoka K, Matsuda S, Minoura K, Yamaguchi H, Ichikawa Y, Mizunuma M, Kobayashi R, Morimoto Y, Takeuchi M, Fukuda K, Nakamura R, Hori S, Yamazaki T, Sambe T, Kawakubo H, Kitagawa Y. Hisaoka K, et al. Among authors: matsuda s. Cancers (Basel). 2024 Apr 27;16(9):1698. doi: 10.3390/cancers16091698. Cancers (Basel). 2024. PMID: 38730650 Free PMC article.
Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study.
Nakayama Y, Onishi A, Yamamoto W, Yoshikawa A, Shiba H, Yoshida N, Son Y, Shirasugi I, Maeda T, Katsushima M, Hashimoto M, Etani Y, Itami T, Nozaki Y, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Matsuda S, Morinobu A. Nakayama Y, et al. Among authors: matsuda s. Clin Exp Med. 2024 May 10;24(1):97. doi: 10.1007/s10238-024-01360-w. Clin Exp Med. 2024. PMID: 38727756 Free PMC article.
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study.
Shiomi M, Watanabe R, Matsuda S, Kotani T, Okazaki A, Masuda Y, Yoshida T, Shoji M, Tsuge R, Kadoba K, Hiwa R, Yamamoto W, Takeda A, Itoh Y, Hashimoto M. Shiomi M, et al. Among authors: matsuda s. Mod Rheumatol. 2024 May 10:roae044. doi: 10.1093/mr/roae044. Online ahead of print. Mod Rheumatol. 2024. PMID: 38727536
The efficacy and safety of anamorelin among patients with diabetes.
Ando K, Naito T, Hamauchi S, Miura K, Nishibori Y, Tonsho A, Matsuda S, Morita M, Sekikawa M, Doshita K, Kodama H, Yabe M, Morikawa N, Iida Y, Mamesaya N, Kobayashi H, Ryo K, Wakuda K, Ono A, Kenmotsu H, Murakami H, Yamazaki K, Takahashi T. Ando K, et al. Among authors: matsuda s. Int J Clin Oncol. 2024 May 9. doi: 10.1007/s10147-024-02546-8. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38722487
Energy landscape analysis and time-series clustering analysis of patient state multistability related to rheumatoid arthritis drug treatment: The KURAMA cohort study.
Yamamoto K, Sakaguchi M, Onishi A, Yokoyama S, Matsui Y, Yamamoto W, Onizawa H, Fujii T, Murata K, Tanaka M, Hashimoto M, Matsuda S, Morinobu A. Yamamoto K, et al. Among authors: matsuda s. PLoS One. 2024 May 6;19(5):e0302308. doi: 10.1371/journal.pone.0302308. eCollection 2024. PLoS One. 2024. PMID: 38709812 Free PMC article.
3,481 results